Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Operating Expenses (2016 - 2025)

Assembly Biosciences has reported Operating Expenses over the past 11 years, most recently at $22.7 million for Q4 2025.

  • Quarterly results put Operating Expenses at $22.7 million for Q4 2025, up 20.02% from a year ago — trailing twelve months through Dec 2025 was $84.4 million (up 14.18% YoY), and the annual figure for FY2025 was $84.4 million, up 14.18%.
  • Operating Expenses for Q4 2025 was $22.7 million at Assembly Biosciences, up from $21.7 million in the prior quarter.
  • Over the last five years, Operating Expenses for ASMB hit a ceiling of $62.9 million in Q4 2021 and a floor of -$55.5 million in Q4 2023.
  • Median Operating Expenses over the past 5 years was $21.2 million (2024), compared with a mean of $19.4 million.
  • Biggest five-year swings in Operating Expenses: crashed 341.59% in 2023 and later skyrocketed 134.03% in 2024.
  • Assembly Biosciences' Operating Expenses stood at $62.9 million in 2021, then tumbled by 63.46% to $23.0 million in 2022, then tumbled by 341.59% to -$55.5 million in 2023, then skyrocketed by 134.03% to $18.9 million in 2024, then rose by 20.02% to $22.7 million in 2025.
  • The last three reported values for Operating Expenses were $22.7 million (Q4 2025), $21.7 million (Q3 2025), and $20.7 million (Q2 2025) per Business Quant data.